Myelin sheaths: Glycoproteins involved in their formation, maintenance and degeneration

Cellular and Molecular Life Sciences

Volumn 59, Issue 11, 2002, Pages 1851-1871

  Quarles, R H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Glycoprotein; Myelin; Myelin associated glycoprotein; Myelin oligodendrocyte glycoprotein; Oligodendrocyte; Peripheral myelin protein 22; Protein zero; Schwann cell

Indexed keywords

GLYCOPROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PERIPHERAL MYELIN PROTEIN 22; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASE; GENE MUTATION; GLIA CELL; HUMAN; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEUROLOGIC DISEASE; NONHUMAN; OLIGODENDROGLIA; PERIPHERAL NERVOUS SYSTEM; REVIEW; SCHWANN CELL;

ANIMALS; CALLITHRIX; CELL MEMBRANE; GLYCOPROTEINS; MICE; MYELIN P0 PROTEIN; MYELIN PROTEINS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE DEGENERATION;

EID: 0036867837     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00012510     Document Type: Review

References (206)

1. Morell P. and Quarles R. H. (1999) Myelin formation, structure and biochemistry. In: Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, 6 Edn., pp. 117-144, Siegel G. J., Agranoff B. W., Albers R. W., Fisher S. K. and Uhler M. D. (eds), Lippincott-Raven, New York
2. Mikol D. D. and Stefansson K. (1988) A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes. J. Cell Biol. 106: 1273-1279
3. Mikol D. D., Gulcher J. R. and Stefansson K. (1990) The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J. Cell Biol. 110: 471-479
4. Mikol D. D., Rongnoparut P., Allwardt B. A., Marton L. S. and Stefansson K. (1993) The oligodendrocyte-myelin glycoprotein of mouse: Primary structure and gene structure. Genomics 17: 604-610
5. Habib A. A., Marton L. S., Allwardt B., Gulcher J. R., Mikol D. D., Hognason T. et al. (1998) Expression of the oligodendrocyte-myelin glycoprotein by neurons in the mouse central nervous system. J. Neurochem. 70: 1704-1711
6. Quarles R. H. (1989) Glycoproteins of myelin and myelin-forming cells. In: Neurobiology of Glycoconjugates, pp. 243-275, Margolis R. U. and Margolis R. K. (eds), Plenum, New York
7. Quarles R., Colman D., Salzer J. and Trapp B. (1992) Myelin-associated glycoprotein: Structure-function relationships and involvement in neurological diseases. In: Myelin: Biology and Chemistry, pp. 4413-4448, Martenson R. (ed.), CRC Press, Boca Raton, FL
8. Quarles R. (1997) Glycoproteins of myelin sheaths. J. Mol. Neurosci. 8: 1-12
9. Scherer S. S. and Arroyo E. J. (2002) Recent progress on the molecular organization of myelinated axons. J. Peripher. Nerv. Syst. 7: 1-12
10. Trapp B. D. and Kidd G. J. (2000) Axo-glial septate junctions. The maestro of nodal formation and myelination? J. Cell Biol. 150: F97-F100
11. Peles E. and Salzer J. L. (2000) Molecular domains of myelinated axons. Curr. Opin. Neurobiol. 10: 558-565
12. Pedraza L., Huang J. K. and Colman D. R. (2001) Organizing principles of the axoglial apparatus. Neuron. 30: 335-344
13. Martini R. and Carenini S. (1998) Formation and maintenance of the myelin sheath in the peripheral nerve: Roles of cell adhesion molecules and the gap junction protein connexin 32. Microsc. Res. Tech. 41: 403-415
14. Fannon A. M., Sherman D. L., Ilyina-Gragerova G., Brophy P. J., Friedrich V. L. Jr and Colman D. R. (1995) Novel E-cadherin-mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions. J. Cell Biol. 129: 189-202
15. Relvas J. B., Setzu A., Baron W., Buttery P. C., LaFlamme S. E., Franklin R. J. et al. (2001) Expression of dominant-negative and chimeric subunits reveals an essential role for beta1 integrin during myelination. Curr. Biol. 11: 1039-1043
16. Scherer S. S. (2002) Myelination: Some receptors required. J. Cell Biol. 156: 13-15
17. Sherman D. L., Fabrizi C., Gillespie C. S. and Brophy P. J. (2001) Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron. 30: 677-687
18. Needham L. K. and Schnaar R. L. (1993) Carbohydrate recognition in the peripheral nervous system: A calcium-dependent membrane binding site for HNK-1 reactive glycolipids potentially involved in Schwann cell adhesion. J. Cell Biol. 121: 397-408
19. Martini R., Schachner M. and Brushart T. M. (1994) The L2/HNK-1 carbohydrate is preferentially expressed by previously motor axon-associated Schwann cells in reinnervated peripheral nerves. J. Neurosci. 14: 7180-191
20. Low K., Orberger G., Schmitz B., Martini R. and Schachner M. (1994) The L2/HNK-1 carbohydrate is carried by the myelin associated glycoprotein and sulphated glucuronyl glycolipids in muscle but not cutaneous nerves of adult mice. Eur. J. Neurosci. 6: 1773-1781
21. O'Shannessy D. J., Willison H. J., Inuzuka T., Dobersen M. J. and Quarles R. H. (1985) The species distribution of nervous system antigens that react with anti-myelin-associated glycoprotein antibodies. J. Neuroimmunol. 9: 255-268
22. Matthieu J. M., Quarles R. H., Poduslo J. F. and Brady R. O. (1975) [35-S]sulfate incorporation into myelin glycoproteins; I. Central nervous system. Biochim. Biophys. Acta. 392: 159-166
23. Matthieu J. M., Everly J. L., Brady R. O. and Quarles R. H. (1975) [35-S]sulfate incorporation into myelin glycoproteins; II. Peripheral nervous tissue. Biochim. Biophys. Acta. 392: 167-174
24. Greenfield S., Brostoff S., Eylar E. H. and Morell P. (1973) Protein composition of myelin of the peripheral nervous system. J. Neurochem. 20: 1207-1216
25. Everly J. L., Brady R. O. and Quarles R. H. (1973) Evidence that the major protein in rat sciatic nerve myelin is a glycoprotein. J. Neurochem. 21: 329-334
26. Wood J. G. and Dawson R. M. C. (1973) A major myelin glycoprotein of sciatic nerve. J. Neurochem. 21: 717-719
27. Gallego R. G., Blanco J. L., Thijssen-van Zuylen C. W., Gotfredsen C. H., Voshol H., Duus J. O. et al. (2001) Epitope diversity of N-glycans from bovine peripheral myelin glycoprotein P0 revealed by mass spectrometry and nano probe magic angle spinning 1H NMR spectroscopy. J. Biol. Chem. 276: 30834-3044
28. Uyemura K., Kitamura K. and Miura M. (1992) Structure and molecular biology of P0 glycoprotein. In: Myelin: Chemistry and Biology, pp. 481-508, Martenson R. E. (ed.), CRC Press, Boca Raton, FL
29. Voshol H., van Zuylen C. W., Orberger G., Vliegenthart J. F. and Schachner M. (1996) Structure of the HNK-1 carbohydrate epitope on bovine peripheral myelin glycoprotein P0. J. Biol. Chem. 271: 22957-22960
30. Brunden K. R. (1992) Age-dependent changes in the oligosaccharide structure of the major myelin glycoprotein, P0. J. Neurochem. 58: 1659-1666
31. Filbin M. T., Walsh F. S., Trapp B. D., Pizzey J. A. and Tennekoon G. I. (1990) Role of myelin Po protein as a homophilic adhesion molecule. Nature 344: 871-872
32. D'Urso D., Brophy P. J., Staugaitis S. M., Gillespie C. S., Frey A. B., Stempak J. G. et al. (1990) Protein zero of peripheral nerve myelin: Biosynthesis, membrane insertion and evidence for homotypic interaction. Neuron 4: 449-460
33. Schneider-Schaulies J., von B. A. and Schachner M. (1990) Recombinant peripheral myelin protein Po confers both adhesion and neurite outgrowth-promoting properties. J. Neurosci. Res. 27: 286-297
34. Filbin M. T. and Tennekoon G. I. (1991) The role of complex carbohydrates in adhesion of the myelin protein, P0. Neuron 7: 845-855
35. Filbin M. T. and Tennekoon G. I. (1993) Homophilic adhesion of the myelin Po protein requires glycosylation of both molecules in the homophilic pair. J. Cell Biol. 122: 451-459
36. Wells C. A., Saavedra R. A., Inouye H. and Kirschner D. A. (1993) Myelin P0-glycoprotein: Predicted structure and interactions of extracellular domain. J. Neurochem. 61: 1987-1995
37. Yazaki T., Miura M., Asou H., Kitamura K., Toya S. and Uyemura K. (1992) Glycopeptide of P0 protein inhibits homophilic cell adhesion: Competition assay with transformants and peptides. FEBS Lett. 307: 361-366
38. Griffith L. S., Schmitz B. and Schachner M. (1992) L2/HNK-1 carbohydrate and protein-protein interactions mediate the homophilic binding of the neural adhesion molecule P0. J. Neurosci. Res. 33: 639-648
39. Wong M. H. and Filbin M. T. (1994) The cytoplasmic domain of the myelin Po protein influences the adhesive interactions of its extracellular domain. J. Cell Biol. 126: 1089-1097
40. Wong M. H. and Filbin M. T. (1996) Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain. J. Cell Biol. 134: 1531-1541
41. Shapiro L., Doyle J. P., Hensley P., Colman D. R. and Hendrickson W. A. (1996) Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17: 435-449
42. Ding Y. and Brunden K. R. (1994) The cytoplasmic domain of myelin glycoprotein P0 interacts with negatively charged phospholipid bilayers. J. Biol. Chem. 269: 10764-10770
43. Eichberg J. and Iyer S. (1996) Minireview: Phosphorylation of myelin proteins: Recent advances. Neurochem. Res. 21: 527-535
44. Martini R., Mohajeri M. H., Kasper S., Giese K. P. and Schachner M. (1995) Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J. Neurosci. 15: 4488-4495
45. Owens G. C. and Boyd C. J. (1991) Expressing antisense P0 RNA in Schwann cells perturbs myelination. Development 112: 639-649
46. Giese K. P., Martini R., Lemke G., Soriano P. and Schachner M. (1992) Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71: 565-576
47. Shy M. E., Arroyo E., Sladky J., Menichella D., Jiang H., Xu W. et al. (1997) Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP). J. Neuropathol. Exp. Neurol. 56: 811-821
48. Martini R., Zielasek J., Toyka K. V., Giese K. P. and Schachner M. (1995) Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 11: 281-286
49. Wrabetz L., Feltri M. L., Quattrini A., Imperiale D., Previtali S., D'Antonio M. et al. (2000) P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J. Cell Biol. 148: 1021-1034
50. Yin X, Kidd G. J., Wrabetz L., Feltri M. L., Messing A. and Trapp B. D. (2000) Schwann cell myelination requires timely and precise targeting of P(0) protein. J. Cell Biol. 148: 1009-1020
51. Lee M., Brennan A., Blanchard A., Zoidl G., Dong Z., Tabernero A. et al. (1997) P0 is constitutively expressed in the rat neural crest and embryonic nerves and is negatively and positively regulated by axons to generate non-myelin-forming and myelin-forming Schwann cells, respectively. Mol. Cell. Neurosci. 8: 336-350
52. Sommer L. and Suter U. (1998) The glycoprotein P0 in peripheral gliogenesis. Cell Tissue Res. 292: 11-16
53. Yazaki T., Miura M., Asou H., Toya S. and Uyemura K. (1994) Peripheral myelin P0 protein mediates neurite outgrowth of cortical neurons in vitro and axonal regeneration in vivo. Neurosci. Lett. 176: 13-16
54. Frei R., Motzing S., Kinkelin I., Schachner M., Koltzenburg M. and Martini R. (1999) Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J. Neurosci. 19: 6058-6067
55. Iyer S., Bianchi R. and Eichberg J. (2000) Tyrosine phosphorylation of PNS myelin P(0) occurs in the cytoplasmic domain and is maximal during early development. J. Neurochem. 75: 347-354
56. Iyer S., Rowe-Rendleman C. L., Bianchi R. and Eichberg J. (1996) Tyrosine phosphorylation of myelin protein PO. J. Neurosci. Res. 46: 531-539
57. Mirsky R., Parkinson D. B., Dong Z., Meier C., Calle E., Brennan A. et al. (2001) Regulation of genes involved in Schwann cell development and differentiation. Prog. Brain Res. 132: 3-11
58. Martini R., Zielasek J. and Toyka K. V. (1998) Inherited demyelinating neuropathies: From gene to disease. Curr. Opin. Neurol. 11: 545-556
59. Kamholz J., Menichella D., Jani A., Garbern J., Lewis R. A., Krajewski K. M. et al. (2000) Charcot-Marie-Tooth disease type 1: Molecular pathogenesis to gene therapy. Brain 123: 222-233
60. Martini R. (2000) Animal models for inherited peripheral neuropathies: Chances to find treatment strategies? J. Neurosci. Res. 61: 244-250
61. Milner P., Lovelidge C. A., Taylor W. A. and Hughes R. A. (1987) P0 myelin protein produces experimental allergic neuritis in Lewis rats. J. Neurol. Sci. 79: 275-285
62. Linington C., Lassmann H., Ozawa K., Kosin S. and Mongan L. (1992) Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: Induction of experimental allergic neuritis (EAN) by P0 protein-specific T ceil lines. Eur. J. Immunol. 22: 1813-1817
63. Zhu J., Pelidou S. H., Deretzi G., Levi M., Mix E., van der Meide P. et al. (2001) P0 glycoprotein peptides 56-71 and 180-199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreading. J. Neuroimmunol. 114: 99-106
64. Khalili-Shirazi A., Atkinson P., Gregson N. and Hughes R. A. (1993) Antibody responses to P0 and P2 myelin proteins in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neuroimmunol. 46: 245-251
65. Dahle C., Ekerfelt C., Vrethem M., Samuelsson M. and Ernerudh J. (1997) T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barre syndrome. J. Neurol. Sci. 153: 54-60
66. Quarles R. and Weiss M. (1999) Autoantibodies associated with peripheral neuropathy. Muscle Nerve. 22: 820-822
67. Weiss M. D., Dalakas M. C., Lauter C. J., Willison H. J. and Quarles R. H. (1999) Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia. J. Neuroimmunol. 95: 174-184
68. Kitamura K., Suzuki M. and Uyemura K. (1976) Purification and partial characterization of two glycoproteins in bovine peripheral nerve myelin membrane. Biochim. Biophys. Acta 455: 806-816
69. Naef R. and Suter U. (1998) Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc. Res. Tech. 41: 359-371
70. Muller H. W. (2000) Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: New facts and hypotheses. Glia 29: 182-185
71. Jetten A. M. and Suter U. (2000) The peripheral myelin protein 22 and epithelial membrane protein family. Prog. Nucleic Acid Res. Mol. Biol. 64: 97-129
72. Bronstein J. M. (2000) Function of tetraspan proteins in the myelin sheath. Curr. Opin. Neurobiol. 10: 552-557
73. Kitamura K., Uyemura K., Shibuya K., Sakamoto Y., Yoshimura K. and Nomura M. (2000) Structure of a major oligosaccharide of PASII/PMP22 glycoprotein in bovine peripheral nerve myelin. J. Neurochem. 75: 853-860
74. Hammer J. A., O'Shannessy D. J., De L. M., Gould R., Zand D., Daune G. et al. (1993) Immunoreactivity of PMP-22, P0, and other 19 to 28 kDa glycoproteins in peripheral nerve myelin of mammals and fish with HNK1 and related antibodies. J. Neurosci. Res. 35: 546-558
75. Snipes G. J., Suter U. and Shooter E. M. (1993) Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J. Neurochem. 61: 1961-1964
76. Ryan M. C., Notterpek L., Tobler A. R., Liu N. and Shooter E. M. (2000) Role of the peripheral myelin protein 22 N-linked glycan in oligomer stability. J. Neurochem. 75: 1465-1474
77. D'Urso D., Ehrhardt P. and Muller H. W. (1999) Peripheral myelin protein 22 and protein zero: A novel association in peripheral nervous system myelin. J. Neurosci. 19: 3396-3403
78. Gabriel J. M., Erne B., Pareyson D., Sghirlanzoni A., Taroni F. and Steck A. J. (1997) Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology 49: 1635-1640
79. Gabriel C. M., Hughes R. A., Moore S. E., Smith K. J. and Walsh F. S. (1998) Induction of experimental autoimmune neuritis with peripheral myelin protein-22. Brain. 121: 1895-1902
80. Gabriel C. M., Gregson N. A. and Hughes R. A. (2000) Anti-PMP22 antibodies in patients with inflammatory neuropathy. J. Neuroimmunol. 104: 139-146
81. Ritz M. F., Lechner-Scott J., Scott R. J., Fuhr P., Malik N., Erne B. et al. (2000) Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies. J. Neuroimmunol. 104: 155-163
82. Quarles R. H. (1989) Myelin-associated glycoprotein in demyelinating disorders. Crit. Rev. Neurobiol. 5: 1-28
83. Quarles R. H., Everly J. L. and Brady R. O. (1973) Evidence for the close association of a glycoprotein with myelin in rat brain. J. Neurochem. 21: 1177-1191
84. McIntyre R. J., Quarles R. H., deF W. H. and Brady R. O. (1978) Isolation and characterization of myelin-related membranes. J. Neurochem. 30: 991-1002
85. Quarles R. H. (1980) The biochemical and morphological heterogeneity of myelin and myelin-related membranes. In: Biochemistry of Brain, pp. 81-102, Kumar S. (ed.), Pergamon Press, Oxford
86. Heape A. M., Lehto V.P. and Kursula P. (1999) The expression of recombinant large myelin-associated glycoprotein cytoplasmic domain and the purification of native myelin-associated glycoprotein from rat brain and peripheral nerve. Protein Expr. Purif. 15: 349-361
87. Norton W. T. and Poduslo S. E. (1973) Myelination in rat brain: Method of myelin isolation. J. Neurochem. 21: 749-757
88. Li C., Tropak M. B., Gerlai R., Clapoff S., Abramow N. W., Trapp B. et al. (1994) Myelination in the absence of myelin-associated glycoprotein. Nature. 369: 747-750
89. Montag D., Giese K. P., Bartsch U., Martini R., Lang Y., Bluthmann H. et al. (1994) Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13: 229-246
90. Schachner M. and Bartsch U. (2000) Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia 29: 154-165
91. Uschkureit T., Sporkel O., Stracke J., Bussow H. and Stoffel W. (2000) Early onset of axonal degeneration in double (plp-/-mag-/-) and hypomyelinosis in triple (plp-/-mbp-/-mag-/-) mutant mice. J. Neurosci. 20: 5225-5233
92. Bartsch U., Montag D., Bartsch S. and Schachner M. (1995) Multiply myelinated axons in the optic nerve of mice deficient for the myelin-associated glycoprotein. Glia 14: 115-122
93. Bartsch S., Montag D., Schachner M. and Bartsch U. (1997) Increased number of unmyelinated axons in optic nerves of adult mice deficient in the myelin-associated glycoprotein (MAG). Brain Res. 762: 231-234
94. Li C., Trapp B., Ludwin S., Peterson A. and Roder J. (1998) Myelin associated glycoprotein modulates glia-axon contact in vivo. J. Neurosci. Res. 51: 210-217
95. Lassmann H., Bartsch U., Montag D. and Schachner M. (1997) Dying-back oligodendrogliopathy: A late sequel of myelin-associated glycoprotein deficiency. Glia 19: 104-110
96. Weiss M. D., Hammer J. and Quarles R. H. (2000) Oligodendrocytes in aging mice lacking myelin-associated glycoprotein are dystrophic but not apoptotic. J. Neurosci. Res. 62: 772-780
97. Fruttiger M., Montag D., Schachner M. and Martini R. (1995) Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur. J. Neurosci. 7: 511-515
98. Yin X., Crawford T. O., Griffin J. W., Tu P., Lee V. M., Li C. et al. (1998) Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 18: 1953-1962
99. Weiss M. D., Luciano C. A. and Quarles R. H. (2001) Nerve conduction abnormalities in aging mice deficient for myelin-associated glycoprotein. Muscle Nerve 24: 1380-1387
100. Kirkpatrick L. L. and Brady S. T. (1999) Cytoskeleton of neurons and glia. In: Basic Neurochemistry: Molecular Cellular and Medical Aspects, 6th Eds., pp. 155-173, Siegel G. J., Agranoff B. W., Albers R. W., Fisher, S. K. and Uhler M. D. (eds), Lippincott-Raven, Philadelphia
101. Biffiger K., Bartsch S., Montag D., Aguzzi A., Schachner M. and Bartsch U. (2000) Severe hypomyelination of the murine CNS in the absence of myelin- associated glycoprotein and fyn tyrosine kinase. J. Neurosci. 20: 7430-7437
102. Umemori H., Sato S., Yagi T, Aizawa S. and Yamamoto T (1994) Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 367: 572-576
103. Marcus J., Dupree J. L. and Popko B. (2002) Myelin-associated glycoprotein and myelin galactolipids stabilize developing axo-glial interactions. J. Cell Biol. 156: 567-577
104. Coetzee T., Dupree J. L. and Popko B. (1998) Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice. J. Neurosci. Res. 54: 613-622
105. Gard A. L., Maughon R. H. and Schachner M. (1996) In vitro oligodendrogliotrophic properties of cell adhesion molecules in the immunoglobulin superfamily: Myelin-associated glycoprotein and N-CAM. J. Neurosci. Res. 46: 415-426
106. Sasagasako N., Toda K., Hollis M. and Quarles R. H. (1996) Myelin gene expression in immortalized Schwann cells: Relationship to cell density and proliferation. J. Neurochem. 66: 1432-1439
107. Sasagasako N., Ohno N. and Quarles R. (1999) Evidence for regulation of myelin protein synthesis by contact between adjacent Schwann cell plasma membranes. Dev. Neurosci. 21: 417-422
108. Carenini S., Montag D., Schachner M. and Martini R. (1999) Subtle roles of neural cell adhesion molecule and myelin-associated glycoprotein during Schwann cell spiralling in P0-deficient mice. Glia 27:2203-212
109. Carenini S., Montag D., Cremer H., Schachner M. and Martini R. (1997) Absence of the myelin-associated glycoprotein (MAG) and the neural cell adhesion molecule (N-CAM) interferes with the maintenance, but not with the formation of peripheral myelin. Cell Tissue Res. 287:3-9
110. Dashiell S. M., Tanner S. L., Pant H. C. and Quarles R. H. (2002) Myelin-associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases. J. Neurochem. 81: 1263-1272
111. Filbin M. T. (1996) The muddle with MAG. Mol. Cell. Neurosci. 8: 84-92
112. Qiu J., Cai D. and Filbin M. T. (2000) Glial inhibition of nerve regeneration in the mature mammalian CNS. Glia. 29: 166-174
113. Sato S., Quarles R. H. and Brady R. O. (1982) Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain. J. Neurochem. 39: 97-105
114. Stebbins J. W., Jaffe H., Fales H. M. and Moller J. R. (1997) Determination of a native proteolytic site in myelin-associated glycoprotein. Biochemistry 36: 2221-2226
115. Stebbins J. W., Jaffe H. and Moller J. R. (1998) Characterization of myelin-associated glycoprotein (MAG) proteolysis in the human central nervous system. Neurochem. Res. 23: 1005-1010
116. Möller J. R., Yanagisawa K., Brady R. O., Tourtellotte W. W. and Quarles R. H. (1987) Myelin-associated glycoprotein in multiple sclerosis lesions: A quantitative and qualitative analysis. Ann. Neurol. 22: 469-474
117. Tang S., Qiu J., Nikulina E. and Filbin M. T. (2001) Soluble myelin-associated glycoprotein released from damaged white matter inhibits axonal regeneration. Mol. Cell. Neurosci. 18: 259-269
118. Hsieh S. T., Kidd G. J., Crawford T. O., Xu Z., Lin W. M., Trapp B. D. et al. (1994) Regional modulation of neurofilament organization by myelination in normal axons. J. Neurosci. 14: 6392-401
119. Aguayo A. J., Bray G. M. and Perkins S. C. (1979) Axon-Schwann cell relationships in neuropathies of mutant mice. Ann. N. Y. Acad. Sci. 317: 512-531
120. de Waegh S. M. and Brady S. T. (1991) Local control of axonal properties by Schwann cells: Neurofilaments and axonal transport in homologous and heterologous nerve grafts. J. Neurosci. Res. 30: 201-212
121. de Waegh S. M., Lee V. M. and Brady S. T. (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell. 68: 451-463
122. Turnley A. M. and Bartlett P. F. (1999) Nerve growth factor modulates myelin-associated glycoprotein binding to sensory neurons. Int. J. Dev. Neurosci. 17: 109-119
123. Kelm S., Pelz A., Schauer R., Filbin M. T., Tang S., de Bellard M. E. et al. (1994) Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol. 4: 965-972
124. Crocker P. R., Clark E. A., Filbin M., Gordon S., Jones Y., Kehrl J. H. et al. (1998) Siglecs: A family of sialic-acid binding lectins [letter]. Glycobiology. 8:v
125. Varki A., Cummings R., Esko J., Freeze H., Hart G. and Marth J. 1999. Essentials of Glycobiology, Cold Spring Harbor Laboratory Press, New York
126. Yang L. J., Zeller C. B., Shaper N. L., Kiso M., Hasegawa A., Shapiro R. E. et al. (1996) Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc. Natl. Acad. Sci. USA 93: 814-818
127. Collins B. E., Ito H., Sawada N., Ishida H., Kiso M. and Schnaar R. L. (1999) Enhanced binding of the neural siglecs, myelin-associated glycoprotein and Schwann cell myelin protein, to Chol-1 (alpha-series) gangliosides and novel sulfated Chol-1 analogs. J. Biol. Chem. 274: 37637-37643
128. Sawada N., Ishida H., Collins B. E., Schnaar R. L. and Kiso M. (1999) Ganglioside GD1 alpha analogues as high-affinity ligands for myelin- associated glycoprotein (MAG). Carbohydr. Res. 316: 1-5
129. Strenge K., Schauer R. and Kelm S. (1999) Binding partners for the myelin-associated glycoprotein of N2 A neuroblastoma cells. FEBS Lett. 444: 59-64
130. Strenge K., Schauer R., Bovin N., Hasegawa A., Ishida H., Kiso M. et al. (1998) Glycan specificity of myelin-associated glycoprotein and sialoadhesin deduced from interactions with synthetic oligosaccharides. Eur. J. Biochem. 258: 677-685
131. Kelm S., Brossmer R., Isecke R., Gross H. J., Strenge K. and Schauer R. (1998) Functional groups of sialic acids involved in binding to siglecs (sialoadhesins) deduced from interactions with synthetic analogues. Eur. J. Biochem. 255: 663-672
132. Schnaar R. L., Collins B. E., Wright L. P., Kiso M., Tropak M. B., Roder J. C. et al. (1998) Myelin-associated glycoprotein binding to gangliosides. Structural specificity and functional implications. Ann. N. Y. Acad. Sci. 845: 92-105
133. Vyas A. A. and Schnaar R. L. (2001) Brain gangliosides: Functional ligands for myelin stability and the control of nerve regeneration. Biochimie. 83: 677-682
134. Sheikh K. A., Sun J., Liu Y., Kawai H., Crawford T. O., Proia R. L. et al. (1999) Mice lacking complex gangliosides develop wallerian degeneration and myelination defects. Proc. Natl. Acad. Sci. USA 96: 7532-7537
135. Vinson M., Strijbos P. J., Rowles A., Facci L., Moore S. E., Simmons D. L. et al. (2001) Myelin-associated glycoprotein interacts with ganglioside GT1 b. A mechanism for neurite outgrowth inhibition. J. Biol. Chem. 276: 20280-20285
136. DeBellard M. E., Tang S., Mukhopadhyay G., Shen Y. J. and Filbin M. T. (1996) Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein. Mol. Cell. Neurosci. 7: 89-101
137. Tang S., Shen Y. J., DeBellard M. E., Mukhopadhyay G., Salzer J. L., Crocker P. R. et al. (1997) Myelin-associated glycoprotein interacts with neurons via a sialic acid binding site at ARG118 and a distinct neurite inhibition site. J. Cell Biol. 138: 1355-1366
138. DeBellard M. and Filbin M. (1999) Myelin-associated glycoprotein, MAG, selectively binds several neuronal proteins. J. Neurosci. 56: 213-218
139. Tanner S. L., Franzen R., Jaffe H. and Quarles R. H. (2000) Evidence for expression of some microtubule-associated protein 1B in neurons as a plasma membrane glycoprotein. J. Neurochem. 75: 553-562
140. Franzen R., Tanner S. L., Dashiell S. M., Rottkamp C. A., Hammer J. A. and Quarles R. H. (2001) Microtubule-associated protein 1B: A neuronal binding partner for myelin-associated glycoprotein. J. Cell Biol. 155: 893-898
141. Fahrig T., Landa C., Pesheva P., Kuhn K. and Schachner M. (1987) Characterization of binding properties of the myelin-associated glycoprotein to extracellular matrix constituents. EMBO J. 6: 2875-2883
142. Probstmeier R., Fahrig T., Spiess E. and Schachner M. (1992) Interactions of the neural cell adhesion molecule and the myelin-associated glycoprotein with collagen type I: Involvement in fibrillogenesis. J. Cell Biol. 116: 1063-1070
143. Bachmann M., Conscience J. F., Probstmeier R., Carbonetto S. and Schachner M. (1995) Recognition molecules myelin-associated glycoprotein and tenascin-C inhibit integrin-mediated adhesion of neural cells to collagen. J. Neurosci. Res. 40: 458-470
144. Yang H., Xiao Z. C., Becker B., Hillenbrand R., Rougon G. and Schachner M. (1999) Role for myelin-associated glycoprotein as a functional tenascin-R receptor. J. Neurosci. Res. 55: 687-701
145. Strenge K., Brossmer R., Ihrig P., Schauer R. and Kelm S. (2001) Fibronectin is a binding partner for the myelin-associated glycoprotein (siglec-4a). FEBS Lett. 499: 262-267
146. Martini R. and Schachner M. (1988) Immunoelectron microscopic localization of neural cell adhesion molecules (L1, NCAM, and myelin-associated glycoprotein) in regenerating adult mouse sciatic nerve. J. Cell Biol. 106: 1735-1746
147. Fujita N., Kemper A., Dupree J., Nakayasu H., Bartsch U., Schachner M. et al. (1998) The cytoplasmic domain of the large myelin-associated glycoprotein isoform is needed for proper CNS but not peripheral nervous system myelination. J. Neurosci. 18: 1970-1978
148. Butt A. M., Ibrahim M., Gregson N. and Berry M. (1998) Differential expression of the L- and S-isoforms of myelin associated glycoprotein (MAG) in oligodendrocyte unit phenotypes in the adult rat anterior medullary velum. J. Neurocytol. 27: 271-280
149. Jaramillo M. L., Afar D. E., Almazan G. and Bell J. C. (1994) Identification of tyrosine 620 as the major phosphorylation site of myelin-associated glycoprotein and its implication in interacting with signaling molecules. J. Biol. Chem. 269: 27240-27245
150. Kursula P., Tikkanen G., Lehto V. P., Nishikimi M. and Heape A. M. (1999) Calcium-dependent interaction between the large myelin-associated glycoprotein and S100 beta. J. Neurochem. 73: 1724-1732
151. Kursula P., Lehto V. P. and Heape A. M. (2000) S100beta inhibits the phosphorylation of the L-MAG cytoplasmic domain by PKA. Brain Res. Mol. Brain Res. 76: 407-410
152. Kursula P., Lehto V. P. and Heape A. M. (2001) The small myelin-associated glycoprotein binds to tubulin and microtubules. Brain Res. Mol. Brain Res. 87: 22-30
153. Kursula P., Merilainen G., Lehto V. P. and Heape A. M. (1999) The small myelin-associated glycoprotein is a zinc-binding protein. J. Neurochem. 73: 2110-2118
154. Kroepfl J. F. and Gardinier M. V. (2001) Mutually exclusive apicobasolateral sorting of two oligodendroglial membrane proteins, proteolipid protein and myelin/oligodendrocyte glycoprotein, in Madin-Darby canine kidney cells. J. Neurosci. Res. 66: 1140-1148
155. Minuk J. and Braun P. E. (1996) Differential intracellular sorting of the myelin-associated glycoprotein isoforms. J. Neurosci. Res. 44: 411-420
156. Quarles R. H. (1990) The biochemistry of myelin in X-linked mutants. Ann. N. Y. Acad. Sci. 605: 135-145
157. Möller J., Durr P., Quarles R. and Duncan I. (1997) Biochemical analysis of myelin proteins in a novel neurological mutant: The taiep rat. J. Neurochem. 69: 773-779
158. Song J., O'Connor L T., Yu W., Baas P. W. and Duncan I. D. (1999) Microtubule alterations in cultured taiep rat oligodendrocytes lead to deficits in myelin membrane formation. J. Neurocytol. 28: 671-683
159. O'Connor L. T., Goetz B. D., Couve E., Song J. and Duncan I. D. (2000) Intracellular distribution of myelin protein gene products is altered in oligodendrocytes of the taiep rat. Mol. Cell. Neurosci. 16: 396-407
160. Song J., Goetz B. D., Kirvell S. L., Butt A. M. and Duncan I. D. (2001) Selective myelin defects in the anterior medullary velum of the taiep mutant rat. Glia 33: 1-11
161. Ebersole T. A., Chen Q., Justice M. J. and Artzt K. (1996) The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins [see comments]. Nat. Genet. 12: 260-265
162. Hardy R. J. (1998) Molecular defects in the dysmyelinating mutant quaking. J. Neurosci. Res. 51: 417-422
163. Frail D. E. and Braun P. E. (1985) Abnormal expression of the myelin-associated glycoprotein in the central nervous system of dysmyelinating mutant mice. J. Neurochem. 45: 1071-1075
164. Fujita N., Sato S., Kurihara T., Inuzuka T., Takahashi Y. and Miyatake T. (1988) Developmentally regulated alternative splicing of brain myelin-associated glycoprotein mRNA is lacking in the quaking mouse. FEBS Lett. 232: 323-327
165. Fujita N., Sato S., Ishiguro H., Inuzuka T., Baba H., Kurihara T. et al. (1990) The large isoform of myelin-associated glycoprotein is scarcely expressed in the quaking mouse brain. J. Neurochem. 55: 1056-1059
166. Bartoszewicz Z. P., Noronha A. B., Fujita N., Sato S., Bo L., Trapp B. D. et al. (1995) Abnormal expression and glycosylation of the large and small isoforms of myelin-associated glycoprotein in dysmyelinating quaking mutants. J. Neurosci. Res. 41: 27-38
167. Wu J. I., Reed R. B., Grabowski P. J. and Artzt K. (2002) Function of quaking in myelination: Regulation of alternative splicing. Proc. Natl. Acad. Sci. USA 99: 4233-4238
168. Bo L., Quarles R. H., Fujita N., Bartoszewicz Z., Sato S. and Trapp B. D. (1995) Endocytic depletion of L-MAG from CNS myelin in quaking mice. J. Cell Biol. 131: 1811-1820
169. Bartoszewicz Z. P., Lauter C. J. and Quarles R. H. (1996) The
170. Inuzuka T., Johnson D. and Quarles R. H. (1987) Myelin-associated glycoprotein in the central and peripheral nervous system of quaking mice. J. Neurochem. 49: 597-602
171. Inuzuka T., Quarles R. H., Heath J. and Trapp B. D. (1985) Myelin-associated glycoprotein and other proteins in Trembler mice. J. Neurochem. 44: 793-797
172. Trapp B. D., Quarles R. H. and Suzuki K. (1984) Immunocytochemical studies of quaking mice support a role for the myelin-associated glycoprotein in forming and maintaining the periaxonal space and periaxonal cytoplasmic collar of myelinating Schwann cells. J. Cell Biol. 99: 594-606
173. Trapp B. D. (1988) Distribution of the myelin-associated glycoprotein and P0 protein during myelin compaction in quaking mouse peripheral nerve. J. Cell Biol. 107: 675-685
174. Heath J. W., Inuzuka T., Quarles R. H. and Trapp B. D. (1991) Distribution of P0 protein and the myelin-associated glycoprotein in peripheral nerves from Trembler mice. J. Neurocytol. 20: 439-449
175. Freeman S. D., Kelm S., Barber E. K. and Crocker P. R. (1995) Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 85: 2005-2012
176. Tropak M. B. and Roder J. C. (1997) Regulation of myelin-associated glycoprotein binding by sialylated cis-ligands. J. Neurochem. 68: 1753-1763
177. Razi N. and Varki A. (1999) Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. Glycobiology 9: 1225-1234
178. Razi N. and Varki A. (1998) Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc. Natl. Acad. Sci. USA 95: 7469-7474
179. Sancho S., Magyar J. P., Aguzzi A. and Suter U. (1999) Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 122: 1563-1577
180. Scherer S. S., Xu Y. T., Nelles E., Fischbeck K., Willecke K. and Bone L. J. (1998) Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 24:8-20
181. Xu W., Manichella D., Jiang H., Vallat J. M., Lilien J., Baron P. et al. (2000) Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis. J. Neurosci. Res. 60: 714-724
182. Martini R. (2001) The effect of myelinating Schwann cells on axons. Muscle Nerve 24: 456-466
183. Vital A. (2001) Paraproteinemic neuropathies. Brain Pathol. 11: 399-407
184. Nobile-Orazio E. and Carpo M. (2001) Neuropathy and monoclonal gammopathy. Curr. Opin. Neurol. 14: 615-620
185. Gabriel J. M., Erne B., Miescher G. C., Miller S. L., Vital A., Vital C. et al. (1996) Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy. Brain 119: 775-787
186. Gabriel J. M., Erne B., Bernasconi L., Tosi C., Probst A., Landmann L. et al. (1998) Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy. Acta Neuropathol. (Berl). 95: 540-546
187. Cai Z., Cash K., Swift J., Sutton-Smith P., Robinson M., Thompson P. D. et al. (2001) Focal myelin swellings and tomacula in anti-MAG IgM paraproteinaemic neuropathy: Novel teased nerve fiber studies. J. Peripher. Nerv. Syst. 6: 95-101
188. Trojaborg W., Hays A. P., van den Berg L., Younger D. S. and Latov N. (1995) Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve 18: 730-735
189. Van den Berg L., Hays A. P., Nobile-Orazio E., Kinsella L. J., Manfredini E., Corbo M. et al. (1996) Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve 19: 637-643
190. Chassande B., Leger J. M., Younes-Chennoufi A. B., Bengoufa D., Maisonobe T., Bouche P. et al. (1998) Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve 21: 55-62
191. Andersson M., Yu M., Soderstrom M., Weerth S., Baig S., Linington C., Solders G. et al. (2002) Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis. Eur. J. Neurol. 9: 243-251
192. Weerth S., Berger T., Lassmann H. and Linington C. (1999) Encephalitogenic and neuritogenic T cell responses to the myelin- associated glycoprotein (MAG) in the Lewis rat. J. Neuroimmunol. 95: 157-164
193. Morris-Downes M. M., McCormack K., Baker D., Sivaprasad D., Natkunarajah J. and Amor S. (2002) Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice. J. Neuroimmunol. 122: 20-33
194. Rodriguez M. and Scheithauer B. (1994) Ultrastructure of multiple sclerosis. Ultrastruct. Pathol. 18: 3-13
195. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M. and Lassmann H. (2000) Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 47: 707-717
196. Lucchinetti C. F., Bruck W., Rodriguez M. and Lassmann H. (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 6: 259-274
197. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M. and Lassmann H. (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain. 122: 2279-2295
198. Bonetti B. and Raine C. S. (1997) Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42: 74-84
199. Rodriguez M. and Lucchinetti C. F. (1999) Is apoptotic death of the oligodendrocyte a critical event in the pathogenesis of multiple sclerosis? Neurology 53: 1615-1616
200. Casaccia-Bonnefil P. (2000) Cell death in the oligodendrocyte lineage: A molecular perspective of life/death decisions in development and disease. Glia 29: 124-135
201. Linington C., Webb M. and Woodhams P. (1984) A novel myelin associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6: 387-396
202. Johns T. G. and Bernard C. C. (1999) The structure and function of myelin oligodendrocyte glycoprotein. J. Neurochem. 72: 1-9
203. Kroepfl J. F. and Gardinier M. V. (2001) Identification of a basolateral membrane targeting signal within the cytoplasmic domain of myelin/oligodendrocyte glycoprotein. J. Neurochem. 77: 1301-1309
204. Iglesias A., Bauer J., Litzenburger T., Schubart A. and Linington C. (2001) T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36: 220-234
205. Genain C. P. and Hauser S. L. (2001) Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus. Immunol. Rev. 183: 159-172
206. Hart B. A., van Meurs M., Brok H. P., Massacesi L., Bauer J., Boon L. et al. (2000) A new primate model for multiple sclerosis in the common marmoset. Immunol. Today 21: 290-297